Lessons learned from Zaire ebolavirus to help address urgent needs for vaccines against Sudan ebolavirus and Marburg virus
The 2014-2016 Ebola virus epidemic in West Africa triggered extensive investments from public and private partners in an attempt to slow the spread of disease and bring the outbreak under control. This significantly accelerated the pace of development of countermeasures against Zaire ebolavirus that...
Saved in:
Main Authors: | Daniel N. Wolfe (Author), Marva J. Taylor (Author), Amanda G. Zarrabian (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2020-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Accounting for population structure reveals ambiguity in the Zaire Ebolavirus reservoir dynamics.
by: Bram Vrancken, et al.
Published: (2020) -
Development of an antigen detection assay for early point-of-care diagnosis of Zaire ebolavirus.
by: Haley L DeMers, et al.
Published: (2020) -
Zaire ebolavirus surveillance near the Bikoro region of the Democratic Republic of the Congo during the 2018 outbreak reveals presence of seropositive bats.
by: Stephanie N Seifert, et al.
Published: (2022) -
Assessment of the ability of V920 recombinant vesicular stomatitis-Zaire ebolavirus vaccine to replicate in relevant arthropod cell cultures and vector species
by: Nicholas A. Bergren, et al.
Published: (2018) -
Ebolaviruses: New roles for old proteins.
by: Diego Cantoni, et al.
Published: (2018)